Retatrutide
Drug timelines are a Plus or Pro feature.
21 regulatory and trial events tracked for Retatrutide, covering 2025-04-18 to 2026-07-30. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Retatrutide (LY3437943) in Participants With Type 2 Diabetes Mellitus Who Have Obesity or Overweight [Phase 3]